{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:23:29Z","timestamp":1761513809549,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008212","name":"College of Medicine, Drexel University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008212","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.clbc.2020.03.011","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T02:07:13Z","timestamp":1586225233000},"page":"e529-e539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Upregulation of Prolactin Receptor Expression and Activation of Prolactin Signaling in an Aggressive Triple-Negative Breast Carcinoma During Pregnancy: A Case Report"],"prefix":"10.1016","volume":"20","author":[{"given":"Nikolay","family":"Popnikolov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8152-9915","authenticated-orcid":false,"given":"Katarzyna","family":"Brzezinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2285-7502","authenticated-orcid":false,"given":"Rebecca M.","family":"Platoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7266-8219","authenticated-orcid":false,"given":"Rhonda","family":"Binnebose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rene","family":"Rothstein-Rubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia T.","family":"Komarnicky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Woodworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2020.03.011_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejogrb.2009.06.030","article-title":"Breast cancer during pregnancy","volume":"147","author":"Vinatier","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.clbc.2020.03.011_bib2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF02305802","article-title":"Pregnancy influences breast cancer stage at diagnosis in women 30 years of age or younger","volume":"3","author":"Anderson","year":"1996","journal-title":"Ann Surg Oncol"},{"issue":"suppl 5","key":"10.1016\/j.clbc.2020.03.011_bib3","doi-asserted-by":"crossref","first-page":"v266","DOI":"10.1093\/annonc\/mdq198","article-title":"Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Pentheroudakis","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2020.03.011_bib4","first-page":"1","article-title":"Delayed childbearing: more women are having their first child later in life","volume":"21","author":"Matthews","year":"2009","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.clbc.2020.03.011_bib5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.breast.2017.07.008","article-title":"Epidemiology and pathophysiology of pregnancy-associated breast cancer: a review","volume":"35","author":"Ruiz","year":"2017","journal-title":"Breast"},{"issue":"suppl 1","key":"10.1016\/j.clbc.2020.03.011_bib6","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.3747\/co.22.2338","article-title":"Outcome of patients with pregnancy during or after breast cancer: a review of the recent literature","volume":"229","author":"Raphael","year":"2015","journal-title":"Curr Oncol"},{"key":"10.1016\/j.clbc.2020.03.011_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10549-016-3989-3","article-title":"The prognosis of women diagnosed with breast cancer before, during and after pregnancy: a meta-analysis","volume":"160","author":"Hartman","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2020.03.011_bib8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10549-017-4224-6","article-title":"Prognosis of pregnancy-associated breast cancer","volume":"163","author":"Lee","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2020.03.011_bib9","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1200\/JCO.2012.45.6335","volume":"31","author":"Amant","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2020.03.011_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0167-8140(86)80151-7","article-title":"Klaas Breur Medal Lecture, 1985. The growth and progression of human tumors: implications for management strategy","volume":"6","author":"Tubiana","year":"1986","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clbc.2020.03.011_bib11","first-page":"3692","article-title":"Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer","volume":"82","author":"Ormandy","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clbc.2020.03.011_bib12","doi-asserted-by":"crossref","first-page":"9079","DOI":"10.18632\/oncotarget.2376","article-title":"Prolactin induces upregulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ER\u03b1 and STAT5","volume":"5","author":"Kavarthapu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.clbc.2020.03.011_bib13","doi-asserted-by":"crossref","first-page":"65602","DOI":"10.18632\/oncotarget.11579","article-title":"Role of EGF\/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cells","volume":"7","author":"Kavarthapu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.clbc.2020.03.011_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13058-015-0582-3","article-title":"Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response","volume":"17","author":"Magbanua","year":"2015","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2020.03.011_bib15","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1038\/sj.onc.1210102","article-title":"Molecular profiling of docetaxel cytotoxicity in breast cancer cells: uncoupling of aberrant mitosis and apoptosis","volume":"26","author":"Hernandez-Vargas","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.clbc.2020.03.011_bib16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3892\/or_00000503","article-title":"Gene expression profile of residual breast cancer after doxorubicin and cyclophosphamide neoadjuvant chemotherapy","volume":"22","author":"Koike Folgueira","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1016\/j.clbc.2020.03.011_bib17","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1158\/1078-0432.CCR-04-1031","article-title":"Immediate gene expression changes after the first course of neoadjuvant chemotherapy in patients with primary breast cancer disease","volume":"10","author":"Modlich","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2020.03.011_bib18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12079-012-0168-0","article-title":"A\u00a0pathway map of prolactin signaling","volume":"6","author":"Radhakrishnan","year":"2012","journal-title":"J\u00a0Cell Commun Signal"},{"key":"10.1016\/j.clbc.2020.03.011_bib19","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1210\/me.2002-0422","article-title":"Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase\/Erk1\/2 and phosphatidylinositol 3-kinase pathways","volume":"17","author":"Acosta","year":"2003","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.clbc.2020.03.011_bib20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1158\/1535-7163.MCT-12-0886","article-title":"Neutralization of prolactin receptor function by monoclonal antibody LFA102, a novel potential therapeutic for the treatment of breast cancer","volume":"12","author":"Damiano","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.clbc.2020.03.011_bib21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fendo.2015.00186","article-title":"Prolactin promotes breast cancer cell migration through actin cytoskeleton remodelling","volume":"6","author":"da Silva","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.clbc.2020.03.011_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12860-016-0109-5","article-title":"Prolactin-induced PAK1 tyrosyl phosphorylation promotes FAK dephosphorylation, breast cancer cell motility, invasion and metastasis","volume":"17","author":"Hammer","year":"2016","journal-title":"BMC Cell Biol"},{"key":"10.1016\/j.clbc.2020.03.011_bib23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.canlet.2015.06.010","article-title":"Anti-metastatic outcome of isoform-specific prolactin receptor targeting in breast cancer","volume":"366","author":"Yonezawa","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clbc.2020.03.011_bib24","doi-asserted-by":"crossref","first-page":"djv338","DOI":"10.1093\/jnci\/djv338","article-title":"The role of prolactin in bone metastasis and breast cancer cell\u2013mediated osteoclast differentiation","volume":"108","author":"Sutherland","year":"2016","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2020.03.011_bib25","first-page":"2150","article-title":"Prolactin-induced protein (PIP)\u2014characterization and role in breast cancer progression","volume":"8","author":"Urbaniak","year":"2018","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.clbc.2020.03.011_bib26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1634\/theoncologist.2012-0340","article-title":"Case\u2013control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancer","volume":"18","author":"Litton","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.clbc.2020.03.011_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1677\/JOE-08-0479","article-title":"Re-evaluation of the prolactin receptor expression in human breast cancer","volume":"201","author":"Galsgaard","year":"2009","journal-title":"J\u00a0Endocrinol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820920300677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820920300677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:19:52Z","timestamp":1761513592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820920300677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1526820920300677"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2020.03.011","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upregulation of Prolactin Receptor Expression and Activation of Prolactin Signaling in an Aggressive Triple-Negative Breast Carcinoma During Pregnancy: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2020.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}